Cargando…
Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune ion channel disorder in which antibodies to different end-plate antigens impair neuromuscular transmission, ultimately leading to muscle weakness and fatigability. In about 85% of patients with MG, autoantibodies against the acetylcholine receptor (AChR) activ...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590807/ https://www.ncbi.nlm.nih.gov/pubmed/37876920 http://dx.doi.org/10.2147/PROM.S408175 |